Canadian Pharmacists Association.Blueprint for Pharmacy. Available: www.pharmacists.ca (accessed November 7, 2010)
2.
Peytremann-BrivevauxIBurnandB. Disease management: A proposal for a new definition. Int J Integr Care2009;9:e16
3.
TsuyukiRTJohnsonJATeoKK. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacotherapy1999;33(9):910–9
4.
McLeanDLMcAlisterFAJohnsonJA. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists — Hypertension (SCRIP-HTN). Arch Intern Med2008;168(21):2355–61
5.
KoshmanSLCharroisTLSimpsonSH. Pharmacist care of patients with heart failure: A systematic review of randomized trials. Arch Intern Med2008;168(7):687–94
JoffresMRHarrietPMacLeanDR. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens2001;14:1099–105
8.
HensrudDD. Clinical preventative medicine in primary care: Background and practice: 3. Delivering preventive screening services. Mayo Clin Proc2000;75:381–5
9.
RosenthalMAustinZTsuyukiRT. Are pharmacists the ultimate barrier to pharmacy practice change?Can Pharm J2010;143:37–42
10.
FarahaniPLevineMGaebelK. Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care. Clin Invest Med2007;30(2):E63–E69
11.
LeenanFHHDumaisJMcInnisNH. Results of the Ontario Survey on the Prevalence and Control of Hypertension. CMAJ2008;178(11):1441–9